Targeting myeloid-derived suppressor cells with gemcitabine to enhance efficacy of adoptive cell therapy in bladder cancer

Overview of attention for article published in Frontiers in immunology, October 2023

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (62nd percentile)
Good Attention Score compared to outputs of the same age and source (78th percentile)

So far, Altmetric has seen 6 X posts from 6 X users, with an upper bound of 42,890 followers.

RT @BladderCaJrnl: Targeting myeloid-derived suppressor cells with gemcitabine to enhance efficacy of adoptive cell therapy in bladder canc…

RT @BladderCaJrnl: Targeting myeloid-derived suppressor cells with gemcitabine to enhance efficacy of adoptive cell therapy in bladder canc…

Targeting myeloid-derived suppressor cells with gemcitabine to enhance efficacy of adoptive cell therapy in bladder cancer. https://t.co/6crQM8IQhm

RT @FrontImmunol: New Research: Targeting myeloid-derived suppressor cells with gemcitabine to enhance efficacy of adoptive cell therapy in…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 2 additional X posts.